Milestone Pharmaceuticals Inc. (MIST) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 6 Buy, 1 Hold.
The consensus price target is $8.00, representing an upside of 294.1% from the current price $2.03.
Analysts estimate Earnings Per Share (EPS) of $-0.63 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.67 vs est $-0.63 (missed -6.7%). 2025: actual $-0.75 vs est $-0.72 (missed -4.8%). Analyst accuracy: 95%.
MIST Stock — 12-Month Price Forecast
$8.00
▲ +294.09% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Milestone Pharmaceuticals Inc., the price target is $8.00.
The average price target represents a +294.09% change from the last price of $2.03.
MIST Analyst Ratings
Buy
Based on 7 analysts giving stock ratings to Milestone Pharmaceuticals Inc. in the past 3 months
EPS Estimates — MIST
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.67
vs Est –$0.63
▼ 6.3% off
2025
Actual –$0.75
vs Est –$0.72
▼ 4.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — MIST
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2025
Actual $0.002B
vs Est $0.004B
▼ 180.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
